Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

AAPL Nears New All-Time High. Is Now the Best Time to Buy Apple Stock?

Apple has seen its share price bounce around quite a bit this year, but it's been mostly up for the world's second largest tech stock.

Intel Stock Spotlight: What’s Happening With Semiconductor Play INTC Right Now?

The chips sector is a fast-moving one, and Intel is among the leaders in this regard. However, the question is whether it can be maintained.

TD Cowen Just Raised Its Price Target on Nvidia (NVDA) Stock

Another earnings beat, another flurry of analyst price target hikes for Wall Street darling Nvidia as NVDA stock pushes above $1,000.

Nvidia Just Issued a Possible Death Sentence for Arista Networks (ANET) Stock

Arista Networks is seemingly in Nvidia's crosshairs. Now investors are pricing in some big disruption, with ANET stock down 4% today.

Move Over Ozempic! 3 New GLP-1 Drugs and Products Coming Soon.

The search for the next GLP-1 drugs that will be blockbuster winners during the next market cycle is on, and here are three contenders.